| Title | Study Id | Date | Description | Pages | Price | Purchase |
| Pet Health to 2014: Products & Services | 2660 | Aug-2010 | US retail spending on pet health products and services will rise 6.5 percent annually through 2014. Pet insurance will be the fastest growing service from a small base. Pharmaceuticals recently became the largest product category--surpassing parasiticides--and will be among the fastest growing, second only to dietary supplements. | 285 | $4,800.00 | Add to Cart |
| Vaccines to 2014 | 2667 | Aug-2010 | This study analyzes the US human and veterinary vaccine industry. It presents historical demand data (1999, 2004, 2009) and forecasts to 2014 and 2019 by vaccine type (e.g., pediatric, hepatitis, biodefense, smallpox, anthrax, influenza, Encephalitis, rabies, SARS, meningococcal, BCG, livestock, companion animal). The study also presents macro- and socioeconomic demand indicator data, details industry structure, evaluates company market share and profiles industry competitors. | 239 | $4,700.00 | Add to Cart |
| Nanotechnology in Health Care to 2014 | 2622 | Jun-2010 | US demand for nanosized medical products will grow 17.1 percent annually through 2014. Cancer and central nervous system disorders will be the fastest growing applications. Nanomedicines will provide the best opportunities, while nanotech medical supplies and devices grow the fastest from a small base. | 351 | $4,800.00 | Add to Cart |
| Food Safety Products to 2014 | 2618 | Apr-2010 | US food safety product demand will rise 6.7 percent annually through 2014, driven by food safety concerns and regulations. The food and beverage processing market will remain dominant, led by the beverage segment. Disinfection and diagnostic products will continue as the most common types, while smart labels and tags will see the fastest growth. | 290 | $4,800.00 | Add to Cart |
| World Wound Management Products to 2013 | 2578 | Feb-2010 | Global wound management product demand will rise 4.6 percent yearly through 2013. Best growth prospects include tissue sealants, foam and alginate wound dressings, growth factors, bioengineered tissue substitutes and anti-adhesion agents. China will be the fastest growing market, while the US remains the largest. | 337 | $5,800.00 | Add to Cart |
| World Nutraceutical Ingredients to 2013 | 2565 | Nov-2009 | Global nutraceutical ingredient demand will rise 6.2 percent annually through 2013. China and India will be the fastest growing national markets while the US remains the largest. Best prospects include soy proteins; additives lutein and lycopene; vitamins A and E; minerals calcium and magnesium; and extracts ginkgo biloba and glucosamine. | 487 | $5,800.00 | Add to Cart |
| Soy Chemicals to 2013 | 2538 | Sep-2009 | US soy chemical demand will grow 7.8 percent annually through 2013, driven by the continued penetration of biodiesel, and by the adoption of alternatives to traditional, petrochemical-based materials in manufacturing. Soy oil derivatives such as methyl soyate, polyols, soy-based foamed plastics, waxes and fatty acids hold particularly good prospects. | 208 | $4,700.00 | Add to Cart |
| World Enzymes to 2013 | 2506 | Aug-2009 | Global enzyme demand will rise 6.3 percent annually through 2013, driven by strong demand in the specialty enzymes segment and good growth in animal feed and ethanol markets. North America and Western Europe will see healthy market gains while the fastest growth remains in developing countries. | 396 | $5,800.00 | Add to Cart |
| Food Safety Products in China to 2013 | 2525 | Jul-2009 | Food safety product demand in China will grow 15 percent annually through 2013. Growth will be driven by ongoing food and beverage output gains, especially processed items, and more focus on food safety and supply chain security. Disinfection products will remain the largest segment while tracking products grow the fastest. | 252 | $5,200.00 | Add to Cart |
| In Vitro Diagnostics to 2013 | 2455 | Mar-2009 | US demand for in vitro diagnostic (IVD) products is forecast to increase 5.4 percent annually through 2013. Clinical chemistry and immunoassay will remain the top two IVD methodologies. Nucleic acid testing products will generate the fastest demand gains while endocrine condition testing remains the largest application. | 373 | $4,800.00 | Add to Cart |
| | | | | | | |
|